Completed PHASE4 INTERVENTIONAL 2-arm NCT02953327

Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau

Sponsor: Bandim Health Project

Conditions Bacille Calmette-Guérin Innate Immunity

Interventions BCG solvent Bacille Calmette-Guerin

Updated 10 times since 2017 Last updated: Apr 22, 2021 Started: Feb 1, 2017 Primary completion: Jun 15, 2017 Completion: Jun 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Bacille Calmette-Guérin and Innate Immunity, this trial is completed. The trial is conducted by Bandim Health Project and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Mar 2022 — Jul 2024 [monthly]

Completed PHASE4
May 2021 — Mar 2022 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2021 — May 2021 [monthly]

Unknown Status PHASE4

▶ Show 5 earlier versions

Mar 2019 — Jan 2021 [monthly]

Unknown Status PHASE4
Feb 2019 — Mar 2019 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE4
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bandim Health Project
Radboud University Medical Center

Data source: Bandim Health Project

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bissau, Guinea-Bissau